Is Hers Legit? Investigating the NYSE-Listed Women's Health Platform

Yes, Hers is a legitimate telehealth company that has been operating since 2018. Headquartered in San Francisco, CA, Hers provides treatments in Weight Loss, Hair Loss, Mental Health, Womens Health, serving patients across the United States through licensed healthcare providers. Hers is the women's health division of NYSE-listed Hims & Hers Health — making it one of only two publicly-traded women's telehealth platforms (alongside Nurx's parent Thirty Madison). Hers holds a A+ rating with the Better Business Bureau.

As a publicly-traded entity (NYSE: HIMS (parent company)), Hers is required to file quarterly and annual financial reports with the Securities and Exchange Commission, providing a level of operational transparency that privately-held competitors cannot match. These SEC filings include audited financial statements, material business risks, and governance disclosures that allow patients, investors, and regulators to independently verify the company's financial health and business practices. This public accountability structure means any significant quality issues or regulatory problems would be disclosed in mandatory filings.

The Better Business Bureau has assigned Hers a A+ rating, which reflects the BBB's assessment of the company's commitment to resolving customer complaints and maintaining ethical business practices. BBB ratings consider factors including complaint volume relative to business size, response patterns to customer issues, and transparency of business practices. A A+ rating indicates that Hers meets the BBB's standards for marketplace trust, though patients should also consult independent review platforms like Trustpilot for a more complete picture.

With 28,000+ patient reviews across platforms including Trustpilot, Hers has accumulated a statistically significant sample of patient feedback. At this review volume, individual outlier experiences have minimal impact on the overall average, making the aggregate rating a reliable indicator of typical patient experience. Their 4.3/5 from 20,000+ combined Hims & Hers reviews demonstrates consistent patient satisfaction across a large population. Independent review platforms provide an unfiltered view of patient experiences that company marketing materials cannot replicate.

Hers offers treatments across 4 categories: Weight Loss, Hair Loss, Mental Health, Womens Health. This breadth of services demonstrates the company's investment in building a complete telehealth platform with multiple clinical specialties, each requiring separate provider expertise, pharmacy relationships, and regulatory compliance. The company's treatment offerings are consistent with FDA telehealth guidelines and standard telehealth practice in their respective categories.

Hers follows a structured telehealth process designed to deliver prescription treatment safely and conveniently, in accordance with FDA telehealth regulations. You visit forhers.com, choose your treatment category, and fill out a women-specific health questionnaire that includes menstrual history, contraceptive use, pregnancy status, and relevant symptoms. A licensed provider — often an OB/GYN, dermatologist, or psychiatrist depending on the treatment — reviews your intake within 24 hours. If you are prescribed medication, it ships in discreet packaging from a licensed pharmacy. You can message your provider at any time through the Hers app for follow-ups, dose changes, or to switch treatments.

The initial health assessment is a critical component of the Hers process, serving as the foundation for safe prescribing decisions. Telehealth health assessments must collect sufficient information for providers to make informed prescribing decisions without an in-person examination. This includes current medications, allergies, relevant medical history, and contraindication screening specific to the requested treatment. Patients should answer all health questions honestly and completely, as inaccurate information could lead to inappropriate prescriptions or missed safety concerns. The Ryan Haight Act requires that telehealth prescribers maintain appropriate provider-patient relationships for controlled substance prescribing.

Once a provider approves your treatment, Hers coordinates prescription fulfillment through their pharmacy network. Hers utilizes the same pharmacy network as its parent company Hims & Hers Health (NYSE: HIMS), dispensing FDA-approved generics and compounded medications from licensed US pharmacies. Compounded weight loss medications are prepared by FDA-registered 503A/503B pharmacies under cGMP protocols. As a publicly-traded entity, their pharmacy partnerships are subject to SEC disclosure requirements and regulatory scrutiny. The prescription-to-delivery timeline varies based on medication type and shipping method, but patients can generally expect to receive their first order within one to two weeks of initial consultation approval. Subsequent refills are typically faster as the pharmacy already has your prescription on file. All pharmacy partners must comply with state board of pharmacy regulations.

Follow-up care is an essential component of responsible telehealth practice, and Hers provides ongoing access to licensed providers after the initial consultation. For ongoing treatments, Hers schedules regular provider check-ins to monitor treatment efficacy, manage side effects, and adjust dosing as needed. This follow-up cadence is particularly important for treatments with dose-escalation protocols, such as GLP-1 weight loss medications, where provider oversight at each dose increase is a standard safety requirement. The HHS telehealth policy framework outlines best practices for ongoing telehealth care management.

Hers offers free standard shipping on all prescription orders, typically arriving in 3-5 business days. Subscriptions auto-refill on a regular cadence, and patients can adjust their delivery schedule or pause shipments through their account. All medications are shipped in discreet packaging with no visible treatment information on the exterior, protecting patient privacy during delivery. Patients should ensure they provide accurate shipping information and are available to receive temperature-sensitive medications promptly, as some treatments (particularly injectable GLP-1 medications) require proper storage upon arrival. For information on HIPAA protections covering your health data during the shipping process, refer to the privacy section below.

Yes, Hers uses real, licensed healthcare providers for all medical consultations and prescriptions. Hers employs female-focused healthcare providers including OB/GYNs, dermatologists, and psychiatrists who understand women's health nuances. Providers review patient questionnaires within 24 hours, and patients can request female providers specifically. The platform includes unlimited follow-up messaging with assigned providers. All providers on the Hers platform must maintain active, unrestricted medical licenses in the states where they practice, which can be independently verified through state medical board databases.

State medical licensing is the primary safeguard ensuring telehealth provider quality. Each state maintains a medical board that issues, renews, and monitors physician licenses, and patients can verify any provider's license status through these public databases maintained by the Federation of State Medical Boards. Hers is responsible for verifying that every provider on their platform holds current, unrestricted licenses in the states where they treat patients. This verification process includes confirming medical school graduation, residency completion, board certification status through the American Board of Medical Specialties, and absence of disciplinary actions. Patients who wish to verify their provider's credentials independently can search the FSMB's DocInfo database or their specific state's medical board website.

The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 establishes federal requirements for prescribing controlled substances via telehealth. This law requires that at least one in-person or qualifying telehealth evaluation occur before a controlled substance can be prescribed. For non-controlled medications (which constitute the majority of treatments prescribed by platforms like Hers), standard telehealth prescribing regulations apply. These regulations require providers to conduct an adequate evaluation, establish a provider-patient relationship, and maintain appropriate medical records. The DEA has established specific pathways for telehealth prescribing that Hers must follow.

Hers's provider model emphasizes breadth across 4 treatment categories, which requires a diverse provider network with specialists in each area. Multi-category platforms must maintain strict credentialing standards across all specialties to ensure that providers only prescribe within their areas of competence. Patients should feel empowered to ask their Hers provider about their specific qualifications and experience with the requested treatment. Provider board certifications can be verified at the ABMS.

Patients can take several steps to verify the legitimacy of their healthcare provider, whether through Hers or any telehealth platform. First, check the provider's license status through the state medical board where they practice. Second, verify their National Provider Identifier (NPI) through the NPPES NPI Registry at npiregistry.cms.hhs.gov. Third, check for any disciplinary actions through the National Practitioner Data Bank. Fourth, confirm board certification through the American Board of Medical Specialties at certificationmatters.org. These verification steps are free, publicly accessible, and provide independent confirmation of a provider's credentials beyond what any telehealth platform reports.

Hers prescribes FDA-approved medications that have undergone rigorous clinical trials demonstrating safety and efficacy. These are the same generic medications available at any retail pharmacy — the telehealth delivery model changes how you access the medication, not the medication itself. FDA-approved generics must demonstrate bioequivalence to the brand-name drug, meaning they deliver the same active ingredient at the same dose with the same therapeutic effect.

The FDA-approved generics prescribed by Hers are manufactured by pharmaceutical companies that undergo regular FDA facility inspections. These inspections verify compliance with current Good Manufacturing Practice (cGMP) standards, including raw material testing, manufacturing process controls, finished product testing, and stability monitoring. Any manufacturing deficiencies identified during inspection must be corrected, and the FDA can issue warning letters, product recalls, or facility shutdowns for significant violations. This regulatory infrastructure protects patients regardless of whether they fill prescriptions through telehealth or traditional pharmacies.

Hers utilizes the same pharmacy network as its parent company Hims & Hers Health (NYSE: HIMS), dispensing FDA-approved generics and compounded medications from licensed US pharmacies. Compounded weight loss medications are prepared by FDA-registered 503A/503B pharmacies under cGMP protocols. As a publicly-traded entity, their pharmacy partnerships are subject to SEC disclosure requirements and regulatory scrutiny. Quality control in pharmaceutical dispensing involves multiple checkpoints: verification of prescription accuracy, drug interaction screening, patient allergy checks, and proper medication storage and handling. These quality control measures are standardized across the pharmacy industry and apply equally to prescriptions filled through telehealth platforms and traditional physician offices.

Patients should understand the regulatory market of their specific medications when evaluating any telehealth platform. For FDA-approved generics like those prescribed by Hers, the medication quality is identical regardless of the dispensing channel. The key question is whether the dispensing pharmacy is properly licensed — which Hers's partners are.

The broader telehealth medication market is evolving, with the FDA, DEA, and state pharmacy boards continuously updating regulations to address new delivery models. Hers operates within this regulatory framework, and patients can independently verify compliance through public databases maintained by the FDA (pharmacy registration), DEA (controlled substance licensing), and state boards of pharmacy (dispensing authorization). These verification tools are freely available online and provide patients with the means to confirm that their medication source meets all applicable regulatory standards.

Hers holds a 8.8/10 overall rating based on 28,000+ patient reviews across multiple platforms, including 4.3/5 from 20,000+ combined Hims & Hers reviews on Trustpilot. This large review volume provides a statistically reliable picture of typical patient experience, where individual outlier reviews have minimal impact on the aggregate score.

Among 28,000+ patient reviews, weight loss is the highest-volume category with a 4.2/5 average. Patients specifically praise the option to try oral medications before committing to injections. Birth control reviews average 4.5/5 for convenience. Hair loss reviews are more mixed (3.8/5), with women noting that results take 4-6 months. The most common positive theme: feeling comfortable with a women-focused platform where providers understand their specific health concerns.. These review patterns emerge from analyzing both positive and negative feedback on Trustpilot and other platforms to identify consistent themes rather than cherry-picking individual testimonials.

When evaluating reviews for Hers or any telehealth platform, patients should consider several factors that affect review reliability. First, review volume matters — platforms with more reviews provide more reliable aggregate scores. Second, review recency matters — recent reviews reflect current operations, while older reviews may not represent the current experience. Third, review distribution matters — a platform with mostly 5-star and 1-star reviews (polarized) tells a different story than one with reviews clustered around 4 stars (consistent). Hers's review profile shows a mature distribution with sufficient volume to draw reliable conclusions.

Common positive themes in Hers reviews include women's telehealth specialist, oral weight loss medications, birth control, and the effectiveness of treatments offered. These positive patterns are consistent with the platform's stated value proposition and suggest that Hers delivers on its core promises for the majority of patients. However, no telehealth platform achieves 100% satisfaction, and understanding the common complaints is equally important for setting realistic expectations.

Independent review platforms like Trustpilot and the Better Business Bureau provide unfiltered patient feedback that company marketing cannot replicate. We recommend checking these sources directly before making a healthcare decision, paying particular attention to reviews from the past 6 months and filtering for reviews that discuss your specific treatment category. Hers's A+ BBB rating reflects their responsiveness to customer complaints through that platform's dispute resolution process.

Hers's pricing is structured as follows: Weight Loss (Oral): from $199/month. Weight Loss (GLP-1): from $299/month. Hair Loss: from $15/month. Mental Health: from $85/month. Birth Control: from $15/month. These prices represent the platform's current listed rates and include the base cost of treatment. Whether additional fees apply depends on the specific treatment plan and payment structure. Understanding the complete cost picture requires examining not just the headline price but also consultation fees, shipping costs, and any recurring charges.

Hers does not accept insurance. However, they're one of the few platforms offering both oral weight loss medications ($199/month) AND injectable GLP-1s ($299/month), giving patients a choice that isn't available at most competitors. HSA/FSA accepted for eligible treatments.. For GLP-1 weight loss treatment specifically, patients should understand that compounded semaglutide and tirzepatide pricing at telehealth platforms reflects the cost of compounding pharmacy preparation, provider consultations, and ongoing monitoring — not just the active ingredient. Brand-name GLP-1 medications (Wegovy, Ozempic, Zepbound, Mounjaro) cost $1,000-1,500/month without insurance, providing important context for evaluating compounded pricing.

Hidden fee analysis: Hers does not charge cancellation fees. Based on our analysis and patient review data, Hers's pricing is generally transparent with the listed rates reflecting the actual out-of-pocket cost. Patients should confirm the total cost during their consultation, including any ancillary fees for shipping upgrades, expedited processing, or add-on services.

Payment options at Hers include standard credit and debit cards. HSA (Health Savings Account) and FSA (Flexible Spending Account) payments are accepted for eligible treatments, which can provide tax advantages of 20-35% depending on your tax bracket. To use HSA/FSA funds, patients typically need to pay with their HSA/FSA debit card or submit receipts for reimbursement. Some platforms also offer financing options through third-party providers like Affirm or CareCredit for patients who prefer to spread payments over several months. Learn more about HIPAA-covered payment protections.

When comparing Hers's pricing to competitors, it is important to compare equivalent services rather than just headline numbers. A lower per-month price that excludes consultation fees, shipping, or dose adjustment charges may not be cheaper than a higher all-inclusive price. Hers's pricing covers the stated services at the listed rates, with patients responsible for any additional costs such as pharmacy dispensing fees or shipping upgrades. We recommend requesting a complete cost breakdown before starting treatment with any telehealth platform.

Yes, Hers accepts most major insurance plans, which is a significant differentiator in the telehealth market where the majority of competitors operate on a cash-pay-only basis. Hers does not accept insurance. However, they're one of the few platforms offering both oral weight loss medications ($199/month) AND injectable GLP-1s ($299/month), giving patients a choice that isn't available at most competitors. HSA/FSA accepted for eligible treatments. Insurance acceptance means lower out-of-pocket costs for covered patients, with many services available at standard copay rates. For patients whose insurance is accepted, Hers handles the claims submission process directly.

For patients with Health Savings Accounts (HSA) or Flexible Spending Accounts (FSA), Hers accepts these payment methods for eligible treatments. HSA and FSA accounts allow patients to pay for qualified medical expenses with pre-tax dollars, effectively reducing the cost by 20-35% depending on the patient's tax bracket. For a $149/month treatment, HSA/FSA payment could save $30-52/month in tax benefits. Detailed information about HIPAA-compliant health accounts and eligible expenses is available from the IRS. Understanding the tax-advantaged payment options available can significantly change the real cost of treatment.

Hers's insurance coordination process works as follows: during signup, you provide your insurance information, and Hers verifies your coverage and benefits. For covered services, Hers submits claims directly to your insurance company, and you are responsible for any copay, coinsurance, or deductible amounts based on your plan. Processing times vary by insurer but typically take 1-2 weeks for verification. If your insurance does not cover a specific treatment, Hers offers cash-pay alternatives at their listed prices.

Patients considering Hers should also explore manufacturer savings programs, patient assistance programs, and generic alternatives that can reduce out-of-pocket costs regardless of insurance status. For weight loss specifically, brand-name GLP-1 manufacturers (Novo Nordisk for Wegovy/Ozempic, Eli Lilly for Zepbound/Mounjaro) offer savings cards for commercially insured patients that can reduce copays significantly. Compounded alternatives like those offered by many telehealth platforms provide a more affordable option for patients without GLP-1 insurance coverage.

The insurance market for telehealth is evolving rapidly, with more insurers covering virtual visits following pandemic-era policy changes as outlined by HHS telehealth policy. Hers's existing insurance acceptance positions them well as coverage expands. Patients should periodically check with their insurer about new telehealth benefits, as plans update coverage annually. The American Telemedicine Association tracks policy changes and provides resources for patients navigating telehealth coverage. The Consolidated Appropriations Act of 2023 extended telehealth flexibilities through 2025, and legislative proposals are underway to make many of these provisions permanent.

Cancel anytime through forhers.com account settings, via support chat, email ([email protected]), or phone (1-800-368-0038). No cancellation fees. Pause options available for patients who want to take a break without losing their account setup.. Understanding the cancellation process before signing up is essential for avoiding unexpected charges. Hers's cancellation policy is designed to give patients flexibility, though the specific terms depend on whether you're on a monthly, quarterly, or annual plan.

Cancel at forhers.com or call 1-800-368-0038. No cancellation fees. Already-shipped medications are non-returnable. Pause subscriptions available as an alternative to cancellation. Quarterly and annual subscribers can contact support for prorated refund consideration.. Telehealth medication refunds are generally limited once medications have been shipped due to pharmaceutical regulations that prevent the resale or redistribution of dispensed medications. This is an industry-wide standard, not specific to Hers. Patients should treat the first month of any telehealth subscription as a commitment and cancel before the next billing cycle if they decide the service is not right for them.

For patients considering Hers, we recommend the following approach to manage subscription risk. First, start with a monthly plan rather than committing to a quarterly or annual plan upfront — monthly plans cost slightly more per month but provide maximum cancellation flexibility. Second, set a calendar reminder 3-5 days before your billing date to evaluate whether you want to continue. Third, document your cancellation if you choose to cancel — take screenshots of the confirmation and note the date, method, and any reference numbers provided. These steps protect you regardless of which telehealth platform you use.

If you experience a billing dispute with Hers, you have several resolution paths available. First, contact Hers's customer support directly — most billing issues can be resolved at this level. Second, if direct resolution fails, file a complaint with the Better Business Bureau, which facilitates mediated dispute resolution. Third, dispute the charge with your credit card company or bank under the Fair Credit Billing Act, which provides consumer protections for unauthorized or disputed charges. Fourth, for systemic issues, file a complaint with your state's attorney general consumer protection division or the Federal Trade Commission.

Hers screens for gender-specific contraindications: birth control prescribing includes DVT/blood clot risk assessment, BMI evaluation, and smoking status check. For weight loss, they offer both oral medications (bupropion/naltrexone) with lower GI side effect profiles AND injectable GLP-1s with standard dose escalation. For hair loss, spironolactone prescribing includes potassium level monitoring guidance. Mental health prescriptions include FDA Black Box warning disclosures for SSRIs in patients under 25.. Every medication and supplement carries potential side effects, and understanding these risks is a critical component of informed healthcare decision-making. The side effects associated with Hers's treatments are well-documented in medical literature and are not unique to the telehealth delivery model — the same medications prescribed at a traditional doctor's office carry identical risk profiles. Complete drug safety information is available through the FDA's drug safety portal.

GLP-1 receptor agonist medications (semaglutide and tirzepatide) carry well-documented side effects that patients should anticipate. According to published clinical research, the most common side effects are gastrointestinal: nausea (affecting approximately 44% of patients in the first month), vomiting (24%), diarrhea (30%), and constipation (24%). These GI effects are typically dose-dependent and most severe during the initial weeks and at each dose escalation step. Clinical trial data demonstrates that GI side effects generally diminish significantly by week 8-12 as the body adapts. Tirzepatide studies show similar GI patterns with the dual GIP/GLP-1 mechanism. Serious but rare risks include pancreatitis, gallbladder disease, and a theoretical risk of medullary thyroid carcinoma based on rodent studies (which is why personal or family history of MTC is an absolute contraindication).

Hers's providers are responsible for screening patients for contraindications before prescribing any treatment, following guidelines established by state medical boards and the Ryan Haight Act. This screening process includes reviewing medical history for conditions that contraindicate treatment, checking current medications for potential drug interactions, and assessing individual risk factors such as age, cardiovascular health, and organ function. Patients who experience unexpected or severe side effects should contact their provider immediately and seek emergency medical attention for symptoms such as chest pain, difficulty breathing, severe allergic reactions, or signs of pancreatitis (persistent severe abdominal pain).

Long-term safety data varies by medication class. Finasteride has over 25 years of post-market data (FDA-approved for hair loss in 1997), with long-term studies confirming that side effects remain within the 1-2% range reported in original clinical trials. Ongoing post-market surveillance by the FDA monitors for rare adverse events that may not appear in clinical trials.

Patients should maintain an open line of communication with their Hers provider regarding any side effects experienced during treatment. Reporting side effects allows providers to adjust dosing, switch medications, or add supportive treatments to manage symptoms. Patients can also report adverse events directly to the FDA through MedWatch (fda.gov/medwatch), which contributes to the post-market surveillance system that protects all patients. Documentation of side effects — including onset timing, severity, duration, and any actions taken — helps providers make informed treatment decisions.

As part of the publicly-traded Hims & Hers Health (NYSE: HIMS), Hers operates under the same data governance framework that faces SEC audit scrutiny. HIPAA compliant with additional SOC 2 certification. Hers explicitly separates women's health data from marketing data, and their privacy policy guarantees reproductive health information is not shared with law enforcement without a court order.. As a telehealth platform handling protected health information (PHI), Hers is subject to the Health Insurance Portability and Accountability Act (HIPAA), which establishes national standards for the protection of individually identifiable health information. Patient data protection is a critical concern in digital healthcare, where sensitive health information is transmitted and stored electronically.

HIPAA's Privacy Rule (45 CFR Part 164) governs how covered entities and their business associates handle protected health information. For Hers, this means implementing administrative safeguards (workforce training, access controls, audit procedures), physical safeguards (facility access controls, device security), and technical safeguards (encryption, access controls, audit logs). Violations of HIPAA can result in civil penalties ranging from $100 to $50,000 per violation (up to $1.5 million per year for repeated violations) and criminal penalties including imprisonment for knowing violations. These regulatory frameworks provide meaningful protection for patient information.

Hers's data collection practices include medical history, current medications, health questionnaire responses, provider communications, prescription records, payment information, and usage analytics. Patients should review Hers's privacy policy (available on their website) to understand specifically what data is collected, how it is used, who it is shared with, and how long it is retained. Key privacy policy provisions to look for include: whether health data is sold to third parties, whether data is shared with advertising networks, and what happens to your data if you cancel your account. The HealthIT.gov telehealth resource provides additional guidance on evaluating telehealth privacy practices.

As a publicly-traded company (NYSE: HIMS (parent company)), Hers faces additional data governance scrutiny through SEC reporting requirements, shareholder accountability, and public disclosure obligations. Any significant data breach or privacy violation would be a material event requiring public disclosure, creating a strong financial incentive to maintain strong data security. This public accountability provides an additional trust signal beyond regulatory compliance alone.

Patients have specific rights regarding their health data under HIPAA and state privacy laws. These include the right to access your medical records, the right to request corrections to inaccurate information, the right to receive an accounting of disclosures (who your data has been shared with), and the right to request restrictions on certain uses of your information. If you believe your privacy has been violated, you can file a complaint with the HHS Office for Civil Rights (hhs.gov/ocr) or your state's attorney general. For Hers patients, exercising these rights typically involves contacting their support team or privacy officer as described in their privacy policy.

When comparing Hers to Nurx, the differences span pricing, treatment scope, provider model, and overall value proposition. Against Nurx, Hers offers a broader treatment range (weight loss, hair loss, mental health) while Nurx specializes in birth control and STI testing with insurance acceptance. Vs Wisp, Hers provides a more complete platform while Wisp focuses narrowly on sexual and reproductive health. Against Noom (behavioral weight loss at $59/month), Hers offers prescription medications that produce faster, more significant weight loss results, though at a higher price point. Understanding these distinctions helps patients choose the platform that best matches their specific needs, budget, and preferences rather than defaulting to the most advertised option.

Pricing comparison: Hers Weight Loss (Oral): from $199/month. Hers Weight Loss (GLP-1): from $299/month. Hers Hair Loss: from $15/month. Hers Mental Health: from $85/month. Hers Birth Control: from $15/month. Against Wisp, Hers offers pricing that is competitive within its market segment. Price should be evaluated alongside included services — a lower monthly rate that excludes consultations, shipping, or dose adjustments may not represent better overall value than a higher all-inclusive price. For medication pricing context, the FDA generic drugs page explains why generics cost less.

Treatment scope and specialization differ significantly between Hers and competitors. Hers offers 4 treatment categories (Weight Loss, Hair Loss, Mental Health, Womens Health), making it one of the broader platforms available. This breadth is valuable for patients who may need multiple treatments, as managing everything through a single platform with a single provider is more convenient than coordinating across multiple services. All platforms must comply with telehealth regulations regardless of treatment scope.

Provider model and consultation quality are often overlooked in platform comparisons. Hers employs female-focused healthcare providers including OB/GYNs, dermatologists, and psychiatrists who understand women's health nuances. Providers review patient questionnaires within 24 hours, and patients can request female providers specifically. The platform includes unlimited follow-up messaging with assigned providers. This provider model determines not just the speed of initial consultation but the quality of ongoing care, side effect management, and treatment optimization. Patients should consider whether they prefer the convenience of asynchronous questionnaire-based reviews or the thoroughness of live video consultations when comparing platforms. All providers should be verifiable through state medical boards and the ABMS.

Patient satisfaction metrics provide an objective basis for comparison. Hers's 8.8/10 rating from 28,000+ reviews (4.3/5 from 20,000+ combined Hims & Hers reviews) on Trustpilot should be compared to competitor ratings with attention to both the score and the review volume. A 4.8/5 rating from 200 reviews carries less statistical weight than a 4.3/5 from 30,000 reviews. Hers's high review volume provides reliable comparison data. We recommend checking current ratings on Trustpilot and the BBB directly, as scores can shift over time.

Hers is the best choice for women who want a single platform for multiple health needs from weight loss to birth control to mental health. Their unique offering of both oral and injectable weight loss options gives patients flexibility other platforms lack. If you primarily need birth control and have insurance, Nurx may be more cost-effective. But for complete women's telehealth with prescription-grade treatments, Hers has the widest coverage.. This assessment is based on analyzing Hers's pricing structure, provider credentials, patient review patterns on Trustpilot, regulatory compliance, and competitive positioning against alternative platforms. Every telehealth platform has strengths and limitations, and the right choice depends on your individual needs, budget, and treatment preferences.

Hers is best suited for: patients who want a complete platform covering multiple health concerns through a single provider relationship. Their key differentiators include women's telehealth specialist, oral weight loss medications, birth control, which position them uniquely in the telehealth market. Patients whose needs align with these strengths will likely have the best experience with Hers.

Key strengths: women's telehealth specialist; oral weight loss medications; birth control; GLP-1 + oral options; menopause support; A+ BBB rating; NYSE: HIMS (parent company) public accountability via SEC filings. Key limitations: the standard telehealth limitation of no in-person physical examination. These limitations are common across the telehealth industry and do not indicate problems specific to Hers.

Overall rating: 8.8/10 based on 28,000+ patient reviews, regulatory compliance verification, pricing analysis, and provider credentialing review. This rating is supported by a statistically significant review volume that provides high confidence in the assessment. We update our assessments regularly based on new patient review data, regulatory changes, and platform updates.

Before starting treatment with Hers or any telehealth platform, we recommend the following steps. First, verify that your specific condition and desired treatment are available through the platform. Second, check current pricing directly on forhers.com as rates may change. Third, review the platform's privacy policy to understand how your health data will be used per HIPAA guidelines. Fourth, prepare to answer health assessment questions honestly and completely for safe prescribing per FDA telehealth standards. Fifth, keep your primary care physician informed about any telehealth treatments you begin. Verify provider credentials through the FSMB and ABMS. Informed patients who take these preparatory steps consistently report the highest satisfaction with telehealth services.